Overview

Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA

Status:
Recruiting
Trial end date:
2024-01-11
Target enrollment:
Participant gender:
Summary
This study will explore the preliminary efficacy of multiple intra-articular injections of LRX712 by evaluating the ability of the drug to restore structural integrity of articular cartilage. Efficacy will be evaluated in the context of the systemic safety and local tolerability of the investigational drug.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals